BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 35765408)

  • 1. miR-338-3p Plays a Significant Role in Casticin-Induced Suppression of Acute Myeloid Leukemia via Targeting PI3K/Akt Pathway.
    Yu K; Wang J; Hou J; Zhang L; Liang H
    Biomed Res Int; 2022; 2022():9214130. PubMed ID: 35765408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor miR-139-5p targets Tspan3 and regulates the progression of acute myeloid leukemia through the PI3K/Akt pathway.
    Zhang R; Tang P; Wang F; Xing Y; Jiang Z; Chen S; Meng X; Liu L; Cao W; Zhao H; Ma P; Chen Y; An C; Sun L
    J Cell Biochem; 2019 Mar; 120(3):4423-4432. PubMed ID: 30367526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of Long Non-Coding RNA LINC01268 on the Malignant Biological Behaviors of Acute Myeloid Leukemia Cells].
    Chen W; Gan DY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1608-1616. PubMed ID: 38071035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mesenchymal stem cell-derived exosomal microRNA-7-5p inhibits progression of acute myeloid leukemia by targeting OSBPL11.
    Jiang D; Wu X; Sun X; Tan W; Dai X; Xie Y; Du A; Zhao Q
    J Nanobiotechnology; 2022 Jan; 20(1):29. PubMed ID: 35012554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ_0009910 sponges miR-491-5p to promote acute myeloid leukemia progression through modulating B4GALT5 expression and PI3K/AKT signaling pathway.
    Wu Y; Zhao B; Chen X; Geng X; Zhang Z
    Int J Lab Hematol; 2022 Apr; 44(2):320-332. PubMed ID: 34709725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory role of RBM39 in acute myeloid leukemia: Mediation through the PI3K/AKT pathway.
    Zhang X; Yang L; Liu X; Nie Z; Liu M; Wang T; Lu Y; Pan Y; Zhan Y; Wang Z; Luo J
    Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119607. PubMed ID: 37852323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway.
    Chen Y; Wang D; Shu T; Sun K; Zhao J; Wang M; Huang Y; Wang P; Zheng H; Cai Z; Yang Z
    Bioengineered; 2021 Dec; 12(2):11410-11422. PubMed ID: 34889689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long noncoding RNA MALAT1/microRNA-598-3p axis regulates the proliferation and apoptosis of retinoblastoma cells through the PI3K/AKT pathway.
    Lin X; Huang X; Wang L; Liu W
    Mol Vis; 2022; 28():269-279. PubMed ID: 36284668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
    Wang L; Liu WX; Huang XG
    Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of miR-144-3p alleviates Doxorubicin-induced heart failure and cardiomyocytes apoptosis via SOCS2/PI3K/AKT axis.
    Zhang D; Pan A; Gu J; Liao R; Chen X; Xu Z
    Chem Biol Drug Des; 2023 Jan; 101(1):24-39. PubMed ID: 35730258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of NEAT1 reverses the radioactive iodine resistance of papillary thyroid carcinoma cell via miR-101-3p/FN1/PI3K-AKT signaling pathway.
    Liu C; Feng Z; Chen T; Lv J; Liu P; Jia L; Zhu J; Chen F; Yang C; Deng Z
    Cell Cycle; 2019 Jan; 18(2):167-203. PubMed ID: 30596336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TET1-mediated microRNA-188-5p promoter hydroxymethylation regulates PTEN/PI3K/AKT signaling pathway in acute myeloid leukemia cells.
    Lu N; Wang X; Wang W; Tang M; Chen J; You H; Wang D
    Arch Biochem Biophys; 2023 Mar; 736():109523. PubMed ID: 36682704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-186-3p attenuates the tumorigenesis of cervical cancer via targeting insulin-like growth factor 1 to suppress PI3K-Akt signaling pathway.
    Lu X; Song X; Hao X; Liu X; Zhang X; Yuan N; Ma H; Zhang Z
    Bioengineered; 2021 Dec; 12(1):7079-7092. PubMed ID: 34551673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
    Li C; Feng S; Chen L
    Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-454-3p promotes apoptosis and autophagy of AML cells by targeting ZEB2 and regulating AKT/mTOR pathway.
    Wang X; Zhong L; Dan W; Chu X; Luo X; Liu C; Wan P; Lu Y; Liu Z; Zhang Z; Liu B
    Hematology; 2023 Dec; 28(1):2223874. PubMed ID: 37313984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MiR-217 Targeting PI3K/Akt Pathway Enhances Sensitivity of Adriamycin to Acute Myeloid Leukemia].
    Gan DY; Wu J; Zhou M; Chen W; Jiang W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):39-44. PubMed ID: 38387897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA‑93 knockdown inhibits acute myeloid leukemia cell growth via inactivating the PI3K/AKT pathway by upregulating DAB2.
    Huang J; Xiao R; Wang X; Khadka B; Fang Z; Yu M; Zhang L; Wu J; Liu J
    Int J Oncol; 2021 Oct; 59(4):. PubMed ID: 34476495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of miR-133a-3p enhances Bufothionine-induced gastric cancer cell death by modulating IGF1R/PI3K/Akt signal pathway mediated ER stress.
    Hu ZH; Wang GJ; Li RX; Zhu TY; Wang ZY; Ding HX; Hu XM
    Life Sci; 2020 Oct; 259():118180. PubMed ID: 32758622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AFAP1-AS1 Promotes Proliferation of Pituitary Adenoma Cells through miR-103a-3p to Activate PI3K/AKT Signaling Pathway.
    Tang H; Zhu D; Zhang G; Luo X; Xie W
    World Neurosurg; 2019 Oct; 130():e888-e898. PubMed ID: 31299308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of microRNA-141-3p Reduces Hypoxia-Induced Apoptosis in H9c2 Rat Cardiomyocytes by Activating the RP105-Dependent PI3K/AKT Signaling Pathway.
    Qin Q; Cui L; Zhou Z; Zhang Z; Wang Y; Zhou C
    Med Sci Monit; 2019 Sep; 25():7016-7025. PubMed ID: 31532760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.